DePuy Synthes

DePuy Synthes is the orthopedic and related surgical-technology business operated within Johnson & Johnson MedTech. The business combines the historic DePuy orthopedic franchise with Synthes, a major developer of trauma-fixation, spine, craniomaxillofacial, and related surgical systems. Johnson & Johnson completed its acquisition of Synthes in 2012 and brought the two businesses together under the DePuy Synthes name. The brand supplies implants, instruments, biologic products, digital tools, and procedure-specific systems used by orthopedic, trauma, spine, sports-medicine, craniomaxillofacial, and neurosurgical teams. Its portfolio spans elective reconstruction and repair, including hip and knee replacement; fracture fixation; spinal stabilization and fusion; treatment of sports injuries; cranial and facial reconstruction; and selected technologies used in neurosurgery. Products are generally sold through hospitals, health systems, ambulatory surgery centers, distributors, and other clinical channels rather than directly to consumers. DePuy Synthes is associated with a broad range of implant and instrument platforms, including the ATTUNE knee system, hip-replacement systems, trauma nails and plates, spine systems such as VIPER, and craniomaxillofacial fixation solutions. The business also develops enabling technologies intended to support surgical planning, navigation, robotics, instrumentation, and data-informed clinical workflows. Product availability and branding can vary by country because medical devices require local regulatory clearances and registrations. Its strategic importance within Johnson & Johnson comes from the scale and breadth of its orthopedic platform. The company competes in markets characterized by high clinical and regulatory requirements, long product-development cycles, surgeon training, hospital purchasing decisions, and the need for evidence supporting safety and performance. The DePuy and Synthes combination expanded Johnson & Johnson's capabilities across both reconstructive orthopedics and trauma, spine, and craniomaxillofacial surgery. DePuy Synthes is not a separately listed public company. It operates as part of Johnson & Johnson MedTech, while Johnson & Johnson remains the publicly traded parent. The brand's present scope is therefore best understood as a major operating business and commercial identity within a larger medical-technology segment, rather than as an independent corporation with its own public ticker.

The roots of DePuy Synthes extend through two different medical-device histories. DePuy began as an orthopedic business in Warsaw, Indiana, in the late nineteenth century and became associated with the development and manufacture of orthopedic appliances, implants, and surgical systems. Its location in Warsaw helped establish that Indiana community as an important center for orthopedic-device manufacturing and innovation. DePuy was later acquired by Johnson & Johnson and became part of the company's medical-device operations. Synthes developed separately as a specialist in internal fixation and surgical treatment of musculoskeletal injuries. Its portfolio became particularly prominent in trauma surgery, where plates, screws, nails, and associated instruments are used to stabilize fractures. The Synthes business also expanded into spine, craniomaxillofacial surgery, and related areas. Its development model emphasized procedure-specific systems, instrumentation, surgeon collaboration, and the standardization of implant techniques. Johnson & Johnson agreed to acquire Synthes in 2011, and the transaction was completed in 2012 after receiving the required approvals. The acquisition was strategically significant because it combined DePuy's established reconstructive-orthopedics presence with Synthes's strong trauma, spine, and craniomaxillofacial franchises. The combined operation was branded DePuy Synthes and became one of the largest orthopedic businesses within Johnson & Johnson's medical-technology portfolio. After the combination, DePuy Synthes continued to organize its activities around clinical specialties rather than a single product category. Reconstruction products addressed hip and knee replacement and other elective orthopedic procedures. Trauma products included fixation systems for fractures of the upper and lower limbs, pelvis, and other anatomical areas. Spine products included implants, instruments, and systems for stabilization and fusion. Sports-medicine activities focused on repair and reconstruction of soft-tissue and joint injuries, while craniomaxillofacial and neurosurgical products addressed cranial, facial, and related surgical needs. The business has also participated in the wider shift toward digitally enabled surgery. Its technology portfolio has included tools for preoperative planning, navigation, robotic or computer-assisted workflows, instrumentation, and data-supported clinical decision-making, subject to the regulatory status and availability of individual products in each market. These capabilities complement rather than replace the company's core implant and instrument franchises. DePuy Synthes operates in a highly regulated industry. New devices and major product changes require regulatory review, and products can be subject to field actions, labeling changes, or market-specific restrictions when safety, manufacturing, or performance issues arise. Hospitals and surgeons also evaluate products on clinical evidence, usability, training, compatibility with existing systems, service, and total procedure economics. These factors make brand reputation and long-term clinical relationships central to the business. Today, DePuy Synthes remains an operating brand within Johnson & Johnson MedTech rather than a separately listed company. Its business identity reflects the integration of the DePuy and Synthes legacies, with a global portfolio spanning reconstruction, trauma, spine, sports medicine, craniomaxillofacial surgery, neurosurgery, and enabling technologies.

• 2012

  Synthes acquisition is completed

  [2]Johnson & Johnson completes acquisition of Synthesjnj.com

  Johnson & Johnson completed the Synthes acquisition and combined it with DePuy to form the DePuy Synthes business.

• 2011

  Johnson & Johnson agrees to acquire Synthes

  [3]Johnson & Johnson to acquire Synthesjnj.com

  Johnson & Johnson announced an agreement to acquire Synthes, subject to customary closing conditions and regulatory approvals.

• 1895

  DePuy is established in Warsaw, Indiana

  [4]Johnson & Johnson heritagejnj.com

  DePuy's origins are traced to the establishment of an orthopedic business in Warsaw, Indiana, helping create the foundation of the later DePuy orthopedic franchise.

A broad, clinically oriented global medical-device platform serving orthopedic reconstruction, trauma, spine, sports medicine, craniomaxillofacial surgery, and neurosurgery through implants, instruments, biologics, and digital surgical technologies.

• Knee replacement

  ATTUNE Knee System

  A DePuy Synthes total-knee-replacement platform designed around implant geometry, fixation, instrumentation, and workflow features intended to support knee arthroplasty. The system is offered in market-specific configurations and indications, with availability governed by local regulatory approvals.

• Trauma fixation

  TFNA Proximal Femoral Nailing System

  An intramedullary nailing platform used in the treatment of selected proximal-femur fractures. It combines a cephalomedullary nail concept with associated implants and instruments for fracture stabilization, subject to the indications and configurations cleared in each market.

• Spine surgery

  VIPER Spine System

  A spine-surgery platform comprising implants and instruments used in procedures such as posterior spinal fixation. The portfolio has included pedicle-screw and minimally invasive workflow options, with specific product indications and availability varying by jurisdiction.

• Orthopedic trauma

  Trauma fixation systems

  A broad family of plates, screws, nails, external-fixation products, and instruments for fracture management. DePuy Synthes organizes these products by anatomy and procedure, including upper- and lower-extremity, pelvis, and other trauma applications.

• Joint reconstruction

  Hip replacement systems

  Implant and instrument systems for total and partial hip arthroplasty. The portfolio includes components intended for different surgical approaches, patient anatomies, fixation strategies, and revision requirements, with individual products regulated separately in local markets.

• Craniomaxillofacial surgery

  Craniomaxillofacial systems

  Plates, screws, meshes, instruments, and related solutions used in cranial and facial reconstruction, trauma repair, and selected neurosurgical or reconstructive procedures. Product scope and labeling depend on the market and applicable regulatory authorization.

• 2012

  Creation of the DePuy Synthes businessStrategy

  Background

  The completed Synthes acquisition gave Johnson & Johnson a combined orthopedic organization covering reconstruction, trauma, spine, and related surgical specialties.

  Action taken

  Johnson & Johnson integrated the Synthes business with DePuy and used the DePuy Synthes name for the combined organization.

  Aftermath

  The combined business became a core orthopedic and surgical-technology platform within Johnson & Johnson MedTech.

  Source

• 2011

  Agreement to acquire SynthesM&A

  Background

  Johnson & Johnson sought to expand its orthopedic and surgical-device platform by combining DePuy with Synthes, whose strengths included trauma, spine, and craniomaxillofacial products.

  Action taken

  Johnson & Johnson announced a definitive agreement to acquire Synthes, subject to regulatory and other closing conditions.

  Aftermath

  The transaction closed in 2012 and led to the creation of the DePuy Synthes operating brand.

  Source

• 2012

  Johnson & Johnson completes acquisition of Synthes[2]Johnson & Johnson completes acquisition of Synthesjnj.com

  M&A

  Johnson & Johnson completed its acquisition of Synthes, creating the foundation for the combined DePuy Synthes orthopedic and surgical-device business.

• 2012

  Johnson & Johnson announces completion of DePuy Synthes integration[2]Johnson & Johnson completes acquisition of Synthesjnj.com

  M&A

  Following the Synthes transaction, Johnson & Johnson presented DePuy Synthes as the name for its expanded orthopedic and related surgical-device organization.

1. 1DePuy Synthes — Johnson & Johnson MedTechjnjmedtech.com
2. 2Johnson & Johnson completes acquisition of Synthesjnj.com
3. 3Johnson & Johnson to acquire Synthesjnj.com
4. 4Johnson & Johnson heritagejnj.com
5. 5DePuy Synthes acquires OrthoSpinhealio.com